Charles Schwab’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $742K | Sell |
346,911
-101,434
| -23% | -$217K | ﹤0.01% | 2998 |
|
|
2025
Q1 | $516K | Sell |
448,345
-40,372
| -8% | -$46.4K | ﹤0.01% | 3076 |
|
|
2024
Q4 | $1.07M | Buy |
488,717
+3,616
| +0.7% | +$7.92K | ﹤0.01% | 2891 |
|
|
2024
Q3 | $1.06M | Buy |
485,101
+17,898
| +4% | +$39K | ﹤0.01% | 2899 |
|
|
2024
Q2 | $1.08M | Buy |
467,203
+82,320
| +21% | +$190K | ﹤0.01% | 2909 |
|
|
2024
Q1 | $2.12M | Buy |
384,883
+61,693
| +19% | +$339K | ﹤0.01% | 2573 |
|
|
2023
Q4 | $798K | Sell |
323,190
-40,195
| -11% | -$99.3K | ﹤0.01% | 2910 |
|
|
2023
Q3 | $12.6M | Buy |
363,385
+107,997
| +42% | +$3.75M | ﹤0.01% | 1791 |
|
|
2023
Q2 | $8.38M | Buy |
255,388
+56,121
| +28% | +$1.84M | ﹤0.01% | 1987 |
|
|
2023
Q1 | $6.68M | Sell |
199,267
-506
| -0.3% | -$17K | ﹤0.01% | 2064 |
|
|
2022
Q4 | $6.55M | Buy |
199,773
+39,311
| +24% | +$1.29M | ﹤0.01% | 2069 |
|
|
2022
Q3 | $5.6M | Buy |
160,462
+62,900
| +64% | +$2.2M | ﹤0.01% | 2156 |
|
|
2022
Q2 | $1.19M | Buy |
97,562
+23,759
| +32% | +$291K | ﹤0.01% | 2725 |
|
|
2022
Q1 | $1M | Buy |
73,803
+2,482
| +3% | +$33.7K | ﹤0.01% | 2845 |
|
|
2021
Q4 | $1.42M | Buy |
+71,321
| New | +$1.42M | ﹤0.01% | 2795 |
|